AstraZeneca says it prioritizes US for RSV drug amid surge in cases

Submitted by mike kraft on

AstraZeneca prioritizes US for RSV drug amid surge in cases AstraZeneca on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was approved in July to prevent the disease in infants and toddlers, as a surge of cases is outpacing supply. Patrick Wingrove,Maggie Fick Reuters

 

 

Country / Region Tags: 
United States
General Topic Tags: 
Treatments
Disease Prevention
Health
Public Health
Research
Scarcity
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -